NEPHRITIC/NEPHROTIC SYNDROME

Embed Size (px)

Citation preview

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    1/37

    NEPHRITIC/NEPHROTICSYNDROMESBY

    DR. SAMUEL.N UWAEZUOKE,MB;BS. FWACP (Paed), Dip Th.

    SENIOR LECTURER/CONSULTANTPAEDIATRICIAN

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    2/37

    OUTLINE

    GENERAL CONSIDERATIONS

    DEFINITION

    AETIOLOGY

    CLINICAL FEATURES

    LABORATORY EVALUATION

    TREATMENT

    DIFFERENTIAL DIAGNOSIS

    PROGNOSIS

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    3/37

    NEPHRITIC SYNDROME

    -SYNONYMS INCLUDE

    ACUTE GLOMERULONEPHRITIS

    ACUTE NEPHRITIS

    ACUTE NEPHRITIC SYNDROME

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    4/37

    GENERAL CONSIDERATIONS

    EACH KIDNEY HAS ABOUT ONE MILLIONNEPHRONS- THE FUNCTIONAL UNIT

    THE NEPHRON RECEIVES BLOOD THROUGHTHE AFFERENT ARTERIOLE

    THE AFFERENT ARTERIOLE FORMS THECAPILLARY TUFTS OR GLOMERULUS-

    REUNITE TO FORM THE EFFERENT ARTERIOLE

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    5/37

    GENERAL CONSIDERATIONS

    THE MAJOR ELEMENTS OF RENALFUNCTION INCLUDE GLOMERULAR

    ULTRAFILTRATION, TUBULAR REABSORPTIONAND TUBULAR SECRETION

    GLOMERULAR CAPILLARY HYDROSTATICPRESSURE GENERATES AN ALMOST

    PROTEIN-FREE FILTRATE OF PLASMA INTOTHE BOWMANS CAPSULE

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    6/37

    GENERAL CONSIDERATIONS

    GLOMERULAR FILTRATION RATE(GFR) ISMAINLY DETERMINED BY THE RELATIVE

    DEGREE OF CONSTRICTION OF AFFERENTAND EFFERENT ARTERIOLE

    ANGIOTENSIN II CAUSES A PREFRENTIALCONSTRICTION OF EFFERENT ARTERIOLE

    RAISING THE GLOMERULAR CAPILLARYPRESSURE AND INCREASE IN GFR.

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    7/37

    DEFINTION

    -A RENAL PATHOLOGY CHARACTERIZED BYABRUPT ONSET OF

    HAEMATURIA(VARIABLE DEGREES)OEDEMA

    HYPERTENSION

    OLIGURIA

    -FOLLOWING INFECTION WITH A VARIETY OFORGANISMS ESPECIALLY BETA-HAEMOLYTICSTREPTOCOCCI

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    8/37

    Aetiology of acute nephriticsyndrome

    POST INFECTIOUS

    Streptococci, staphylococci ,treponemapallidum, salmonella typhi, leptospirosis.

    Plasmodium malariae, toxoplasma.

    Hepatitis B and C , cytomegalovirus,parvovirus, Ebstein Barr virus

    Infections of shunts, prostheses, bacterialendocarditis

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    9/37

    Aetiology of acute nephriticsyndrome

    SYSTEMIC VASCULITIS

    Henoch Schonlein purpura, Systemic lupus

    erythematosusMicroscopic polyarteritis, Wegeners

    granulomatosis

    OTHERS

    Membranoproliferative glomerulonephritis Ig A nephropathy

    Acute interstitial nephritis

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    10/37

    PATHOGENESIS

    -POST STREPTOCOCCAL ACUTEGLOMERULONEPHRITIS ( PSGN )

    AS THE PROTOTYPE OF AGN REMAINS THE COMMONEST CAUSE IN

    DEVELOPING COUNTRIES

    OFTEN FOLLOWS PHARYNGITIS, IMPETIGO

    OR RARELY A MIDDLE EAR INFECTIONCAUSED BY GROUP A BETA-HEMOLYTICSTREPTOCOCCI

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    11/37

    PATHOGENESIS The nephritogenic strains of streptococci are

    capable of producing AGN

    These include several protein M-types such as4,12,25 and 49

    Host factors, genetically determined, areimportant in the formation of antibodies tostreptococcal antigens

    Glomerular injury in PSGN results fromdeposition of immune complexes in theglomerular capillaries

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    12/37

    PATHOGENESIS Nephritogenic antigens derived from

    streptococci may bind directly to sub-

    epithelial glomerular sites Antibodies formed against these antigens

    combine(immune complexes) and result in aninflammatory response

    Activation of complement, infiltration of

    neutrophils, proliferation of glomerular cellsand expansion of mesangial matrixfollow(glomerular injury).

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    13/37

    CLINICAL FEATURES

    History of sore throat or pyoderma(impetigenous lesions) is noted in most

    cases Latent period in the history of sore throat is

    7 to 14 days while that of pyoderma is 2 to4 weeks

    Peak age incidence : 5 to 12 years. Rarebelow the age of 3 years

    A male preponderance is reported

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    14/37

    CLINICAL FEATURES

    Gross hematuria and mild facial edemaare the most common presenting features

    Urine usually cola coloured or reddishbrown

    Oliguria ( less than 0.5ml-1ml/kg/hour )orsometimes anuria

    Hypertension(from volume overload) maylead to headache

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    15/37

    CLINICAL FEATURES

    Atypical presentations (complications ofAGN) include

    - Acute pulmonary edema

    - Hypertensive encephalopathy(even atcomparatively lower BP levels)

    - Acute renal failure

    - Nephrotic syndrome( so-called nephriticnephrotic syndrome)

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    16/37

    LABORATORY INVESTIGATIONS

    Urinalysis- mild proteinuria

    Urine microscopy- dysmorphic red cells,

    red cell casts, and neutrophils. Hyalineand granular casts may also be seen.

    Serum electrolyte, urea and creatinine-elevated urea/creatinine, hyperkalemia,metabolic acidosis( in patients with ARF ).

    Hematology- anemia due tohemodilution

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    17/37

    LABORATORY INVESTIGATIONS

    Imaging study(Chest X-ray)- may showcardiomegaly and pulmonary congestion

    Serology ( ASO titre and C3 levels)-elevated ASO titre within 3 to 5 weeksafter streptococcal infection, anddecreased serum C3 levels

    Renal biopsy- not required in typical casesbut indicated under special conditions

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    18/37

    Indications for renal biopsy inAGN

    Associated systemic features like fever, rash,joint pain, heart disease.

    Normal ASO titre and C3 levels Mixed picture of AGN and Nephrotic

    syndrome

    Delayed cases of resolution

    -oliguria, hypertension and/or azotemia beyond

    2 weeks, gross hematuria past 3-4 weeks, lowC3 levels past 6-8 weeks and microscopichematuria/proteinuria beyond 6-12 months

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    19/37

    TREATMENT

    GENERAL MEASURES

    - Fluid balance : strict input/output if oliguria is

    present, daily weight measurement.- Diet : restriction of sodium intake in all children

    with edema or hypertension, restriction of

    foods high in potassium until oliguria resolves

    - Bed rest: if hypertension, edema or cardiacfailure are present

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    20/37

    TREATMENT

    Drug treatment:

    - Eradication of streptococcal infections

    using penicillin or alternativelyerythromycin.

    - Intravenous furosemide(1mg/kg) foredema and circulatory congestion

    - For hypertension, the use of vasodilators(hydralazine, nifedipine, ACEI) may beeffective

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    21/37

    DIFFERENTIAL DIAGNOSIS

    Acute interstitial nephritis

    Shunt nephritis

    Nephritis in SBE

    Glomerulonephritis associated withhepatitis B or C

    Ig A nephropathy

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    22/37

    Prognosis

    Most cases resolve within the first week

    Gross hematuria rapidly clears but

    microscopic hematuria may be detectedfor 6 to 12 months

    The long-term prognosis of PSGN inchildren is excellent

    Even those with severe diseasecompletely recover

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    23/37

    NEPHROTIC SYNDROME

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    24/37

    NEPHROTIC SYNDROME

    Not a distinct renal disease

    A clinical and biochemical state that maydevelop during the course of severaldifferent renal diseases of known andunknown aetiology

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    25/37

    CAUSES/ CLASSIFICATION

    CONGENITAL :

    - FINNISH TYPE (AUTOSOMAL RECESSIVE)

    - MICROCYSTIC KIDNEY DISEASE(CONGENITAL NEPHROSIS)

    - INTRAUTERINE INFECTIONS SUCH ASSYPHILIS, CMV, TOXOPLASMA

    ACQUIRED :IDIOPATHIC OR PRIMARY ANDSECONDARY

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    26/37

    CAUSES/CLASSIFICATION PRIMARY / IDIOPATHIC: Minimal change

    nephropathy (MCN), Mesangial proliferative

    GN, Focal segmental glomerulosclerosis (FSG),Membranoproliferative GN (MPGN), andMembranous nephropathy

    SECONDARY: Systemic lupuserythematosus(SLE), Henoch-Schonleinpurpura (HSP), amyloidosis, hepatitis B, HIV, P.malariae, SCD, Bee stings, Gold salts/ heavymetals such as mercury etc.

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    27/37

    Minimal change nephroticsyndrome( MCNS)

    Occurs in about 85% of children withidiopathic nephrotic syndrome

    Often steroid responsive

    Onset usually between the age of 2-6years

    More common in boys

    Hypertension, hematuria and raised urealevels are rare

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    28/37

    PATHOGENESIS OF NEPHROTICSYNDROME

    Increasedglomerular

    permeability

    Gross proteinuria

    Hypoalbuminaemia

    hyperlipidaemia

    Reduced oncoticpressure

    Diminished effectiveplasma volume

    Oedema- due tosalt/water retention

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    29/37

    Clinical features of MCNS Insidious onset with periorbital swelling and

    facial puffiness

    Swelling gradually increases to involve theextremities and abdomen and if untreated

    may become massive resulting in anasarca

    May occasionally be associated with gross

    hematuria and oliguria ( mixed picture of

    nephrotic syndrome and acute nephritis)

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    30/37

    LABORATORY EVALUATION Urinalysis : dipstick test(3+/4+), spot urine test or

    protein/creatinine concentrations (ratios

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    31/37

    TREATMENT Initial episode:

    - Control of massive edema and infection

    before starting steroid therapy- Oral prednisolone 2mg/kg in 2 to 3 divided

    doses for 6weeks and single morning dose

    alternate days for the next 6 weeks

    - Prolonging the treatment for 6 months mayresult in a longer remission and fewer relapses

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    32/37

    TREATMENT PATTERN OF RESPONSE TO STEROID THERAPY:

    Remission: Protein-free urine(urine proteinnegative or trace) for 3 consecutive days

    Relapse: Proteinuria(urine protein 3+ or more)for 3 consecutive days

    Frequent relapser: 2 or more relapses within 6months of initial episode or more than 3relapses within any 12 month period

    Steroid dependent: 2 consecutive relapsesduring alt. day pred. or within 2 weeks ofstopping therapy

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    33/37

    TREATMENT

    ALTERNATIVE OR ADJUNCT DRUGS USED INFREQUENT RELAPSES AND STEROID

    DEPENDENCE INCLUDE; LEVAMISOLE

    CYCLOPHOSPHAMIDE

    CYCLOSPORINE A

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    34/37

    TREATMENT Use of ACEI : Enalapril, Lisinopril ( anti-

    proteinuric effect)

    Management of edema: diuretics,intravenous albumin or pooled plasmatransfusion

    Dietary management: high biologicalvalue protein, salt restriction, supplementsof vitamins and micronutrients

    Management of complications

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    35/37

    Complications of Nephroticsyndrome

    Infections : peritonitis, cellulitis

    Hypovolemia

    Thromboembolism

    Hyperlipidemia

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    36/37

    DIFFERENTIAL DIAGNOSIS

    Angioneurotic edema

    Protein-losing enteropathy

    Chronic liver disease

    Malnutrition with edema

    Congestive heart failure

  • 7/28/2019 NEPHRITIC/NEPHROTIC SYNDROME.

    37/37

    Prognosis

    The final outcome of steroid sensitivenephrotic syndrome is excellent

    Most patients stop getting relapsesbetween the ages of 14 to 20 years

    Fully recover without any residualdysfunction

    Some may continue to have relapses intoadulthood